Guangzhou Sinogen Pharmaceutical Co., Ltd
Clinical trials sponsored by Guangzhou Sinogen Pharmaceutical Co., Ltd, explained in plain language.
-
Bacteria vs. cancer: modified salmonella starves tumors in new trial
Disease control Recruiting nowThis study tests a modified Salmonella bacteria (SGN1) injected directly into tumors to see if it is safe and can shrink advanced solid tumors that have not responded to other treatments. The bacteria are designed to grow inside tumors and cut off their food supply (methionine), …
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Sinogen Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 09, 2026 04:20 UTC
-
Bacteria engineered to starve tumors enters human trials
Disease control Recruiting nowThis study tests a modified Salmonella bacteria (SGN1) designed to grow inside tumors and cut off their food supply. About 70 adults with advanced solid tumors that have not responded to standard therapy will receive the treatment. The main goals are to check safety and see if th…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Sinogen Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 08, 2026 12:01 UTC